公开(公告)号：US20170290818A1

公开(公告)日：2017-10-12

申请号：US15514414

申请日：2015-09-22

Applicant: GlaxoSmithKline Intellectual Property Development Limited

Inventor： Niall Andrew ANDERSON ,  Matthew Howard James CAMPBELL-CRAWFORD ,  Ashley Paul HANCOCK ,  Seble LEMMA ,  Simon John Fawcett MACDONALD ,  John Martin PRITCHARD ,  Panayiotis Alexandrou PROCOPIOU ,  Stephen SWANSON

IPC: A61K31/4375 ,  C07D207/04 ,  C07D471/04

CPC classification number: A61K31/4375 ,  C07D207/04 ,  C07D471/04

Abstract: A compound according to formula (I) wherein R1 is hydrogen, cyclopropyl, or pyrazolyl, wherein said pyrazolyl is optionally substituted by one or two methyl groups; or a pharmaceutically acceptable salt thereof.